Revista Clínica Española (English Edition)

ISSN: 2254-8874

Revista Clínica Española published its first issue in 1940 and is the body of expression of the Spanish Society of Internal Medicine (SEMI).
The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. Revista Clínica Española is subject to a thorough double blind review of the received articles written in Spanish or English. Ten issues are published each year, including mostly originals, reviews and consensus documents.

Indexed in:

Medline

RSS

Contact

Tienda

Alert

Newsletter

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

Impact factor 2025

1.7

Citescore

CiteScore measures average citations received per document published.

Citescore 2024

4.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2024

0.477

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2024

0.607

View more metrics

Open Access Option

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Original

Estudio observacional de práctica clínica real para evaluar la efectividad y la seguridad de los anticoagulantes orales de acción directa en comparación con antagonistas de la vitaminaK en la prevención secundaria de la trombosis venosa en pacientes con síndrome antifosfolipídico trombótico de bajo riesgo. Protocolo del estudio DOACS-APS

Real-world observational study to evaluate the effectiveness and safety of direct oral anticoagulants compared with vitaminK antagonists for secondary venous thrombosis prevention in low-risk thrombotic antiphospholipid syndrome patients: DOACS-APS protocol

I. Perales Frailea, M. Martín Asenjob, C.L. de Ancos Aracilc, J. Torres Machod, L. Sáez Comete, M. Martín Cascónf, J. Alijotas Reigg, A. González Garcíah, A. Franco Morenod,

Corresponding author

anaisabel.franco@salud.madrid.org

Autor para correspondencia.

a Servicio de Medicina Interna, Hospital Universitario Infanta Sofia, Universidad Europea de Madrid. FIIB HUIS-HUHEN, San Sebastián de los Reyes, Madrid, España

b Servicio de Medicina Interna, Hospital Clínico Universitario de Valladolid, Universidad de Valladolid, Valladolid, España

c Servicio de Medicina Interna, Unidad de Tromboembolismo Venoso, Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, España

d Servicio de Medicina Interna, Unidad de Tromboembolismo Venoso, Hospital Universitario Infanta Leonor, Universidad Complutense de Madrid, Madrid, España

e Servicio de Medicina Interna, Unidad de Enfermedades Autoinmunes Sistémicas, Hospital Universitario Miguel Servet, Zaragoza, España

f Servicio de Medicina Interna, Unidad de Enfermedades Autoinmunes Sistémicas, Hospital General Universitario Morales Meseguer, Murcia, España

g Servicio de Medicina Interna, Unidad de Enfermedades Autoinmunes Sistémicas, Hospital Universitario Vall d’Hebron, Universidad Autónoma de Barcelona, Barcelona, España

h Servicio de Medicina Interna, Unidad de Enfermedades Autoinmunes Sistémicas, Hospital Universitario Ramón y Cajal, IRYCIS, grupo GEAS, Madrid, España

Read

987

Times
was read the article

Total PDF

968

Total HTML

Share statistics

Facebook

Bluesky

E-mail

Article information

ISSN: 00142565
Original language: Spanish

DOI:10.1016/j.rce.2026.502564

The statistics are updated each day

Year/Month	Html	Pdf	Total
2026 10	44	0	44
2026 9	165	2	167
2026 8	95	2	97
2026 7	437	9	446
2026 6	174	4	178
2026 5	53	2	55

Follow this link to access the full text of the article

Statistics

Subscribe to our newsletter